ALKEM

Alkem Laboratories Shareholding Pattern

₹5,343.00+0.96%
Market cap
₹63,884 crore
P/E
29.6
P/B
4.62
ROE
17.8%
Dividend yield
0.19%

As of 30-JUN-2026, promoters held 49.70% of Alkem Laboratories (-1.50 pp from 31-MAR-2026), foreign institutional investors 10.42%, domestic institutions 22.63% and the public 17.25%.

Alkem Laboratories shareholding pattern

Percentage of shares held, by quarter, newest first.

Alkem Laboratories shareholding by category (% of equity)
Holder30-JUN-202631-MAR-202631-DEC-202530-SEP-202530-JUN-202531-MAR-2025Change
Promoters49.70%51.20%51.20%51.20%53.04%n/a-1.50 pp
Foreign institutions (FII/FPI)10.42%10.16%9.97%9.48%9.11%n/a+0.26 pp
Domestic institutions (DII)22.63%21.40%21.54%21.93%21.80%n/a+1.23 pp
Governmentn/a0.00%n/a0.00%0.00%n/a—
Public17.25%17.25%17.30%17.40%16.05%n/a0.00 pp

Source: Shareholding patterns filed with the stock exchanges (company filings). Data as of 7 October 2026. How this data is compiled.

Alkem Laboratories shareholding pattern — frequently asked questions

What is the promoter holding in Alkem Laboratories?

Promoters held 49.70% of Alkem Laboratories as of 30-JUN-2026, down 1.50 pp from 51.20% in 31-MAR-2026.

How much do FIIs hold in Alkem Laboratories?

Foreign institutional investors held 10.42% of Alkem Laboratories as of 30-JUN-2026, a change of +0.26 pp from the previous quarter.

How much do domestic institutions hold in Alkem Laboratories?

Domestic institutional investors, including mutual funds and insurers, held 22.63% of Alkem Laboratories as of 30-JUN-2026 (+1.23 pp from the previous quarter).

Who owns Alkem Laboratories?

As of 30-JUN-2026, Alkem Laboratories' shareholders were promoters (49.70%), foreign institutional investors 10.42%, domestic institutions 22.63% and the public 17.25%, as filed with the stock exchanges.

Same Data For Peers

Trade Alkem Laboratories With ATS

Track ALKEM live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.

Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.